Source:http://linkedlifedata.com/resource/pubmed/id/10597083
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1999-12-28
|
pubmed:abstractText |
We investigated the spontaneous conversion rate of new-onset atrial fibrillation (AF) in emergency department patients and the recurrence rate of AF during a 1 month follow-up period. Sixty-six consecutive hemodynamically stable patients presenting to a university hospital emergency department with new-onset atrial fibrillation (less than 72 hours duration) comprised the study population. Patients were initially monitored for 8 hours and observed for spontaneous conversion of AF to sinus rhythm. If conversion did not occur in the first 8 hours, an oral loading dose (600 mg) of propafenone was given, and patients were observed for an additional 8 hours. All patients were reevaluated at 24 hours and at 1 month. The spontaneous conversion rate in patients presenting within 6 hours of AF onset during the initial 8-hour observation period was 71%. The spontaneous conversion rate for all patients during the initial observation period was 53%. The conversion rates between patients presenting "early" (less than 6 hours) and "late" (7-72 hours) were significantly different (P < 0.001). Many patients with new-onset AF, especially those with atrial fibrillation duration less than 6 hours, may need observation only, rather than immediate intervention, to treat their dysrhythmia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0735-6757
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
17
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
659-62
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:10597083-Administration, Oral,
pubmed-meshheading:10597083-Aged,
pubmed-meshheading:10597083-Anti-Arrhythmia Agents,
pubmed-meshheading:10597083-Atrial Fibrillation,
pubmed-meshheading:10597083-Drug Monitoring,
pubmed-meshheading:10597083-Emergency Treatment,
pubmed-meshheading:10597083-Female,
pubmed-meshheading:10597083-Follow-Up Studies,
pubmed-meshheading:10597083-Humans,
pubmed-meshheading:10597083-Male,
pubmed-meshheading:10597083-Middle Aged,
pubmed-meshheading:10597083-Propafenone,
pubmed-meshheading:10597083-Recurrence,
pubmed-meshheading:10597083-Remission, Spontaneous,
pubmed-meshheading:10597083-Time Factors
|
pubmed:year |
1999
|
pubmed:articleTitle |
Must antidysrhythmic agents be given to all patients with new-onset atrial fibrillation?
|
pubmed:affiliation |
Department of Emergency Medicine, Dokuz Eylul University Medical Center, Izmir, Turkey.
|
pubmed:publicationType |
Journal Article
|